Browse drugs

…plasmic immune checkpoint, constraining immune cell activation. NX-1607 is a first-in-class, orally bioavailable, small-molecule inhibi…

…2 and Flu 30 mg/m2 x 4 days, followed by a one-time infusion of IMA203 (1-10x 109 TCR T cells), and low-dose IL-2 (1 M IU QD x5 days, …

…ond or progress on CI treatment. Clinical data demonstrate that AdAPT-001 induces a tumor-specific inflammatory response, reverses the tu…

…ttps://doi.org/10.1016/j.annonc.2022.01.051Kang M, Yoo S, Ma S. BAL0891 as a dual kinase inhibitor inducing anti-tumor immunity: A prom…

…Background For over 30 years, microbial immunotherapy with Bacillus Calmette-Guérin (BCG) has been the standard-of-care for non-muscle invasive bla…

…ally, we observed VISTA upregulation on myeloid cells following Aza treatment.Conclusions Immune evasion and exhaustion are recogni…

…nd T cells results in enhanced target cell killing when mAb and bsAb are given together. These data provide further support for eval…

…2 exposure, indicating robust immune activation associated with WTX-124. Ex vivo multiplex IF analysis of tumor tissues revealed an ele…

…normal tissues. Here, we present a novel tri-specific antibody, TJ-RO4B, which specifically targets two distinct epitopes of ROR1 in a …

… 10th Revision (ICD-10) healthcare database diagnosis codes for lithium toxicity at hospital admission in Ontario, Canada.Design Popula…

…seline characteristics and main outcomes of patients initiating BGF after dual therapyConclusion In the ORESTES study conducted in …

…g associated with T2 asthmaWe propose that the Rev-erba agonist SR9009, will protect against HDM induced airway inflammation and assoc…